1. Home
  2. HCKT vs AVXL Comparison

HCKT vs AVXL Comparison

Compare HCKT & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hackett Group Inc (The).

HCKT

Hackett Group Inc (The).

N/A

Current Price

$14.06

Market Cap

392.0M

ML Signal

N/A

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

N/A

Current Price

$4.63

Market Cap

388.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HCKT
AVXL
Founded
1991
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
392.0M
388.7M
IPO Year
1998
2013

Fundamental Metrics

Financial Performance
Metric
HCKT
AVXL
Price
$14.06
$4.63
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$17.00
$22.00
AVG Volume (30 Days)
320.3K
1.0M
Earning Date
05-19-2026
04-27-2026
Dividend Yield
3.38%
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
$285,862,000.00
N/A
Revenue This Year
$2.55
N/A
Revenue Next Year
$5.07
N/A
P/E Ratio
$30.87
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.76
$2.86
52 Week High
$29.52
$13.99

Technical Indicators

Market Signals
Indicator
HCKT
AVXL
Relative Strength Index (RSI) 41.28 56.55
Support Level $12.76 $3.60
Resistance Level $21.13 $4.88
Average True Range (ATR) 0.57 0.26
MACD 0.26 0.05
Stochastic Oscillator 62.56 57.57

Price Performance

Historical Comparison
HCKT
AVXL

About HCKT Hackett Group Inc (The).

The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: